Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data
J Hepatol
.
2024 Oct 16:S0168-8278(24)02634-5.
doi: 10.1016/j.jhep.2024.10.014.
Online ahead of print.
Authors
Wukun Ge
1
,
Zhen Wei
2
,
Haiyan Xie
3
Affiliations
1
Department of clinical Pharmacy, Ninghai First Hospital, Zhejiang Province 315600, China.
2
Department of Orthopedics, Ninghai First Hospital, Zhejiang 315600, China.
3
Department of clinical Pharmacy, The Third Hospital of Quzhou, Quzhou, Zhejiang, 324003China. Electronic address:
[email protected]
.
PMID:
39423863
DOI:
10.1016/j.jhep.2024.10.014
No abstract available
Publication types
Letter